BERLIN (Reuters) – Swiss drugs regulator Swissmedic said on Tuesday it is reviewing an application from pharmaceutical company Pfizer for a new dosage recommendation for a COVID-19 booster shot for children.
The regulator said it was looking at the data submitted and assessing the benefits and risks of recommending a booster shot administered at least six months after basic immunisation for children between ages 5 and 11.
(Writing by Miranda Murray; Editing by Madeline Chambers)
